Home
|
Contact Us
|
Site Map
|
Search
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Biotherapeutics
Patents
Academic Access
Technology Licensing
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Home
> News
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
04/17/2007
Lexicon Reports on Anti-angiogenesis Target Discoveries
04/12/2007
Lexicon to Report First Quarter 2007 Financial Results on May 1, 2007
03/20/2007
Lexicon Genetics Appoints Tamar Howson Executive Vice President of Business Development
02/27/2007
Lexicon Genetics Elects Kathleen Wiltsey to Board of Directors
02/26/2007
Lexicon Announces Executive Management Promotions
02/20/2007
Lexicon Genetics Reports 2006 Fourth Quarter and Full Year Financial Results
02/07/2007
Lexicon to Report Fourth Quarter and Full Year 2006 Financial Results on February 21, 2007
01/29/2007
Lexicon Advances LX6171 for Cognitive Disorders into Phase 1b Clinical Trial
01/29/2007
Lexicon Genetics Changing Name, Refocusing Business to Achieve Goal of Advancing Ten Drug Candidates into Human Clinical Trials by 2010
01/23/2007
Lexicon Genetics Initiates Clinical Trials of LX1031 for Irritable Bowel Syndrome
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 6 of 32
back to top
